Capital Allocation

Hertz is issuing $100M in stock but won't see a dime. We deconstruct the complex financial engineering that reveals a company under pressure and betting big.

Vedanta Group's historic demerger splits the conglomerate into five focused firms. This bold move aims to unlock value and power India's growth.

A slight dip in Neuberger Private Equity's NAV masks a flurry of strategic moves, from lucrative exits to aggressive buybacks, revealing a playbook for thriving in a disconnected market.

Amid a stock surge, Glass House Brands forces a warrant exercise, a strategic move to inject cash and clean its books for a potential major exchange listing.

An activist investor challenges Samsung's governance at its security unit, S-1, exposing deep undervaluation and a failure to embrace a connected future.

Amidst a 71% profit plunge, homebuilder KB Home is betting its future on a 'Built to Order' model. A deep dive into whether this strategic pivot can deliver.

A record $63.8 trillion is now held by the ultra-wealthy. Altrata's new report reveals how AI, new geographic hubs, and entrepreneurs are reshaping this elite class.

Ninepoint's new buyback for its split corp is a calculated move. We deconstruct the strategy and what it reveals about their confidence and market view.

Sunbelt hits record revenue, powered by its Specialty division and a key acquisition, but a closer look reveals margin pressure and operational challenges.

FMC's $114M sale-leaseback reflects a wider trend of monetizing real estate. We analyze the deal's impact on its debt, R&D, and what it signals for the market.

Sunstone sells the Hyatt Regency SF to Blackstone for $279M, a deal signaling a strategic shift for the REIT and a major bet on the city's comeback.

HLS Therapeutics is betting on itself with a larger share buyback. We analyze if this is a signal of deep value or a sign of limited growth opportunities.

Hyperscale Data builds a $46M Bitcoin treasury while planning a 590MW AI data center empire, forcing a strategic split and raising investor questions.

The mREIT just authorized a massive share repurchase, signaling deep confidence. But what does this move reveal about its strategy in a volatile RMBS market?

Vivos Therapeutics gets more time from its lender to raise capital, a crucial move as it navigates Nasdaq compliance issues and funds a major business overhaul.

Genius Group's massive share repurchase program aims to boost shareholder value, but a look at its financials reveals a high-stakes gamble. Is this a confident bet or a red flag?

Behind a routine financial announcement lies a masterclass in capital strategy. We dissect Great-West Lifeco's latest move and what it signals.

Leading Edge Materials holds Europe's rare earth keys, but a 'going concern' warning reveals a critical flaw in the continent's resource strategy.

XAI proposes a major sub-adviser shift for its XFLT and OCTIX funds to King Street Capital. What does this move mean for investors and the funds' strategy?

While crypto exchanges tout record trading on SpaceX derivatives, a behind-the-scenes failure to secure actual shares reveals a deep rift with traditional finance.